Upgrade to SI Premium - Free Trial

Goldman Sachs Downgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Sell

April 23, 2026 2:12 PM
Goldman Sachs analyst Shyam Srinivasan downgraded Dr. Reddy\'s Laboratories (DRRD:IN) (NYSE: RDY) from Neutral to Sell with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades Hot Comments Hot Downgrades Intl Ratings